{
  "success": true,
  "pagesUsed": [
    1,
    3
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "SYNOPSIS",
        "text": "SYNOPSIS",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "SYNOPSIS",
        "sectionType": {
          "id": "fb266508-35ac-4fc1-a172-63cfe8d170ce",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "INTRODUCTION",
        "text": "INTRODUCTION",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "INTRODUCTION",
        "sectionType": {
          "id": "4ef6a40b-b05c-497a-89f7-f45b3f916d40",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2"
        ]
      },
      {
        "id": "nc_3",
        "name": "STUDY OBJECTIVES AND ENDPOINTS",
        "text": "STUDY OBJECTIVES AND ENDPOINTS",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "STUDY OBJECTIVES AND ENDPOINTS",
        "sectionType": {
          "id": "9c20548a-e159-4997-ae3f-ede7326e2ec1",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_3_1",
          "nci_3_2",
          "nci_3_3",
          "nci_3_4",
          "nci_3_5"
        ]
      },
      {
        "id": "nc_4",
        "name": "INVESTIGATIONAL PLAN",
        "text": "INVESTIGATIONAL PLAN",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "INVESTIGATIONAL PLAN",
        "sectionType": {
          "id": "8b05c7aa-5d1c-4105-905b-a11afdc961eb",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3"
        ]
      },
      {
        "id": "nc_5",
        "name": "STUDY ACTIVITIES",
        "text": "STUDY ACTIVITIES",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "STUDY ACTIVITIES",
        "sectionType": {
          "id": "eb83143e-a6f3-4ef5-b8e1-cad261ac1b00",
          "code": "Study Procedures",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Procedures",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1",
          "nci_5_2",
          "nci_5_3",
          "nci_5_4",
          "nci_5_5",
          "nci_5_6",
          "nci_5_7",
          "nci_5_8",
          "nci_5_9"
        ]
      },
      {
        "id": "nc_6",
        "name": "SAFETY CONSIDERATIONS",
        "text": "SAFETY CONSIDERATIONS",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "6",
        "sectionTitle": "SAFETY CONSIDERATIONS",
        "sectionType": {
          "id": "16621bbd-7d6b-418e-82fe-5c8e9ba03a83",
          "code": "Safety",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Safety",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_6_1"
        ]
      },
      {
        "id": "nc_7",
        "name": "STATISTICAL METHODS & DETERMINATION OF SAMPLE SIZE",
        "text": "STATISTICAL METHODS & DETERMINATION OF SAMPLE SIZE",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "7",
        "sectionTitle": "STATISTICAL METHODS & DETERMINATION OF SAMPLE SIZE",
        "sectionType": {
          "id": "48d38d58-4aec-4c3a-a0bc-132c9383e224",
          "code": "Statistics",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Statistics",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_8",
        "name": "STUDY SPECIFIC ABBREVIATIONS AND TERMS",
        "text": "STUDY SPECIFIC ABBREVIATIONS AND TERMS",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX A",
        "sectionTitle": "STUDY SPECIFIC ABBREVIATIONS AND TERMS",
        "sectionType": {
          "id": "6b9c8387-8312-402c-a4c7-1a11d9ca4184",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_9",
        "name": "RESPONSIBILITIES OF THE INVESTIGATOR",
        "text": "RESPONSIBILITIES OF THE INVESTIGATOR",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX B",
        "sectionTitle": "RESPONSIBILITIES OF THE INVESTIGATOR",
        "sectionType": {
          "id": "55c012f2-8e09-4745-adec-69387e33bd49",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_10",
        "name": "LIST OF PROTOCOL SIGNATORIES",
        "text": "LIST OF PROTOCOL SIGNATORIES",
        "order": 9,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX C",
        "sectionTitle": "LIST OF PROTOCOL SIGNATORIES",
        "sectionType": {
          "id": "4633ecfa-270c-41ec-9e81-570c880c85dc",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_11",
        "name": "ACTIVITY SCHEDULE",
        "text": "ACTIVITY SCHEDULE",
        "order": 10,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX D",
        "sectionTitle": "ACTIVITY SCHEDULE",
        "sectionType": {
          "id": "d2ebf9bd-93f8-46f3-810f-76b21f49d2c7",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_12",
        "name": "PROTOCOL SUMMARY OF CHANGES",
        "text": "PROTOCOL SUMMARY OF CHANGES",
        "order": 11,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX E",
        "sectionTitle": "PROTOCOL SUMMARY OF CHANGES",
        "sectionType": {
          "id": "df6f0a91-77f4-4cf8-a970-95a7b102478d",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_13",
        "name": "OPERATIONS MANUAL",
        "text": "OPERATIONS MANUAL",
        "order": 12,
        "instanceType": "NarrativeContent",
        "sectionNumber": "APPENDIX F",
        "sectionTitle": "OPERATIONS MANUAL",
        "sectionType": {
          "id": "e4113ed4-c5af-4fbf-8fdd-2ef8fd1fa875",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_2_1",
        "name": "BACKGROUND AND RATIONALE",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "BACKGROUND AND RATIONALE"
      },
      {
        "id": "nci_2_2",
        "name": "BENEFITS AND RISKS TO SUBJECTS",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "BENEFITS AND RISKS TO SUBJECTS"
      },
      {
        "id": "nci_3_1",
        "name": "OBJECTIVES",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "OBJECTIVES"
      },
      {
        "id": "nci_3_2",
        "name": "PRIMARY ENDPOINTS",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.2",
        "sectionTitle": "PRIMARY ENDPOINTS"
      },
      {
        "id": "nci_3_3",
        "name": "SECONDARY ENDPOINTS",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3",
        "sectionTitle": "SECONDARY ENDPOINTS"
      },
      {
        "id": "nci_3_4",
        "name": "EXPLORATORY ENDPOINT",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.4",
        "sectionTitle": "EXPLORATORY ENDPOINT"
      },
      {
        "id": "nci_3_5",
        "name": "EXPLORATORY RESEARCH: BIOMARKER RESEARCH ENDPOINTS",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.5",
        "sectionTitle": "EXPLORATORY RESEARCH: BIOMARKER RESEARCH ENDPOINTS"
      },
      {
        "id": "nci_4_1",
        "name": "OVERALL STUDY DESIGN AND PLAN",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1",
        "sectionTitle": "OVERALL STUDY DESIGN AND PLAN"
      },
      {
        "id": "nci_4_2",
        "name": "DISCUSSION OF STUDY DESIGN",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2",
        "sectionTitle": "DISCUSSION OF STUDY DESIGN"
      },
      {
        "id": "nci_4_3",
        "name": "LOADING DOSE, CONTINUOUS INFUSION RATES, TITRATION, AND EXTRA DOSES",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.3",
        "sectionTitle": "LOADING DOSE, CONTINUOUS INFUSION RATES, TITRATION, AND EXTRA DOSES"
      },
      {
        "id": "nci_5_1",
        "name": "ELIGIBILITY CRITERIA",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "ELIGIBILITY CRITERIA"
      },
      {
        "id": "nci_5_2",
        "name": "CONTRACEPTION RECOMMENDATIONS",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.2",
        "sectionTitle": "CONTRACEPTION RECOMMENDATIONS"
      },
      {
        "id": "nci_5_3",
        "name": "PROHIBITED MEDICATIONS AND THERAPY",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.3",
        "sectionTitle": "PROHIBITED MEDICATIONS AND THERAPY"
      },
      {
        "id": "nci_5_4",
        "name": "PRIOR AND CONCOMITANT THERAPY",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.4",
        "sectionTitle": "PRIOR AND CONCOMITANT THERAPY"
      },
      {
        "id": "nci_5_5",
        "name": "WITHDRAWAL OF SUBJECTS AND DISCONTINUATION OF STUDY",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.5",
        "sectionTitle": "WITHDRAWAL OF SUBJECTS AND DISCONTINUATION OF STUDY"
      },
      {
        "id": "nci_5_6",
        "name": "TEMPORARY SUSPENSION OF STUDY DRUG TREATMENT",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.6",
        "sectionTitle": "TEMPORARY SUSPENSION OF STUDY DRUG TREATMENT"
      },
      {
        "id": "nci_5_7",
        "name": "FOLLOW-UP AFTER SUBJECT DISCONTINUATION OF STUDY DRUG OR FROM STUDY",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.7",
        "sectionTitle": "FOLLOW-UP AFTER SUBJECT DISCONTINUATION OF STUDY DRUG OR FROM STUDY"
      },
      {
        "id": "nci_5_8",
        "name": "STUDY DRUG AND STUDY DEVICES",
        "text": "",
        "order": 7,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.8",
        "sectionTitle": "STUDY DRUG AND STUDY DEVICES"
      },
      {
        "id": "nci_5_9",
        "name": "PROTOCOL DEVIATIONS",
        "text": "",
        "order": 8,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.9",
        "sectionTitle": "PROTOCOL DEVIATIONS"
      },
      {
        "id": "nci_6_1",
        "name": "COMPLAINTS AND ADVERSE EVENTS",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.1",
        "sectionTitle": "COMPLAINTS AND ADVERSE EVENTS"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "EudraCT",
        "expandedText": "European Union Drug Regulating Authorities Clinical Trials",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "M15-741",
        "expandedText": "Study Number",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 13,
      "itemCount": 20,
      "abbreviationCount": 2
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "STUDY M15-741",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "7.0",
      "versionDate": "Not specified",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9",
        "nc_10",
        "nc_11",
        "nc_12",
        "nc_13"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "EudraCT",
          "expansion": "European Union Drug Regulating Authorities Clinical Trials"
        },
        {
          "abbreviation": "M15-741",
          "expansion": "Study Number"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "STUDY M15-741",
        "version": "7.0",
        "versionDate": "Not specified"
      },
      "sections": [
        {
          "number": "1",
          "title": "SYNOPSIS",
          "type": "Synopsis"
        },
        {
          "number": "2",
          "title": "INTRODUCTION",
          "type": "Introduction",
          "subsections": [
            {
              "number": "2.1",
              "title": "BACKGROUND AND RATIONALE"
            },
            {
              "number": "2.2",
              "title": "BENEFITS AND RISKS TO SUBJECTS"
            }
          ]
        },
        {
          "number": "3",
          "title": "STUDY OBJECTIVES AND ENDPOINTS",
          "type": "Objectives",
          "subsections": [
            {
              "number": "3.1",
              "title": "OBJECTIVES"
            },
            {
              "number": "3.2",
              "title": "PRIMARY ENDPOINTS"
            },
            {
              "number": "3.3",
              "title": "SECONDARY ENDPOINTS"
            },
            {
              "number": "3.4",
              "title": "EXPLORATORY ENDPOINT"
            },
            {
              "number": "3.5",
              "title": "EXPLORATORY RESEARCH: BIOMARKER RESEARCH ENDPOINTS"
            }
          ]
        },
        {
          "number": "4",
          "title": "INVESTIGATIONAL PLAN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "4.1",
              "title": "OVERALL STUDY DESIGN AND PLAN"
            },
            {
              "number": "4.2",
              "title": "DISCUSSION OF STUDY DESIGN"
            },
            {
              "number": "4.3",
              "title": "LOADING DOSE, CONTINUOUS INFUSION RATES, TITRATION, AND EXTRA DOSES"
            }
          ]
        },
        {
          "number": "5",
          "title": "STUDY ACTIVITIES",
          "type": "Study Procedures",
          "subsections": [
            {
              "number": "5.1",
              "title": "ELIGIBILITY CRITERIA"
            },
            {
              "number": "5.2",
              "title": "CONTRACEPTION RECOMMENDATIONS"
            },
            {
              "number": "5.3",
              "title": "PROHIBITED MEDICATIONS AND THERAPY"
            },
            {
              "number": "5.4",
              "title": "PRIOR AND CONCOMITANT THERAPY"
            },
            {
              "number": "5.5",
              "title": "WITHDRAWAL OF SUBJECTS AND DISCONTINUATION OF STUDY"
            },
            {
              "number": "5.6",
              "title": "TEMPORARY SUSPENSION OF STUDY DRUG TREATMENT"
            },
            {
              "number": "5.7",
              "title": "FOLLOW-UP AFTER SUBJECT DISCONTINUATION OF STUDY DRUG OR FROM STUDY"
            },
            {
              "number": "5.8",
              "title": "STUDY DRUG AND STUDY DEVICES"
            },
            {
              "number": "5.9",
              "title": "PROTOCOL DEVIATIONS"
            }
          ]
        },
        {
          "number": "6",
          "title": "SAFETY CONSIDERATIONS",
          "type": "Safety",
          "subsections": [
            {
              "number": "6.1",
              "title": "COMPLAINTS AND ADVERSE EVENTS"
            }
          ]
        },
        {
          "number": "7",
          "title": "STATISTICAL METHODS & DETERMINATION OF SAMPLE SIZE",
          "type": "Statistics"
        },
        {
          "number": "APPENDIX A",
          "title": "STUDY SPECIFIC ABBREVIATIONS AND TERMS",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX B",
          "title": "RESPONSIBILITIES OF THE INVESTIGATOR",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX C",
          "title": "LIST OF PROTOCOL SIGNATORIES",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX D",
          "title": "ACTIVITY SCHEDULE",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX E",
          "title": "PROTOCOL SUMMARY OF CHANGES",
          "type": "Appendix"
        },
        {
          "number": "APPENDIX F",
          "title": "OPERATIONS MANUAL",
          "type": "Appendix"
        }
      ]
    }
  }
}